Augmented Sensory in Cancer-Related Neuropathic Patients"

Inclusion Criteria: * Forty female with age from 35-60 years * clinically diagnosed with CIPN after recovery from stage I or II breast cancer * The strength at the toes, ankles, knees, and hips, as determined by manual muscle tests, of at least 3/5. * The patients can walk independently with or without any assistive devices. Exclusion Criteria: * Patients with a history of hereditary peripheral neuropathy * Diseases that may contribute to peripheral nerve damage, such as diabetes or renal insufficiency, alcohol abuse, HIV, and vasculitis. * Patient who had central or peripheral neurologic disease, brain or spinal cord metastases * Orthopedic problems influencing gait, or foot ulcer at the moment of intake. * Patients with vestibular or neurological problems influencing gait parameters * Subjects who had participated in regular exercise, as defined as 150 min of light-to-moderate intensity exercise per week over the past year, were excluded from this trial.